
Research
Semaglutide and the Science of Longevity: What the New Nature Study Reveals About GLP-1, Aging, and God's Design for a Long Life
September 10, 2026
A landmark 2026 Nature study shows that semaglutide, the active compound in Ozempic and Wegovy, extends lifespan and slows biological aging in animal models. Human clinical data from Nature Communications confirms a 9% slower pace of aging on epigenetic clocks. This is not a story about weight loss. It is a story about stewardship, science, and what it means to care for the body God designed for a long and purposeful life.
Read more